Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction

References

• Schuleri KH, Boyle AJ, Hare JM. Mesenchymal stem cells for cardiac regenerative therapy. Bone Marrow-Derived Progenitors, K Kauser, AM Zeiher. Springer-Verlag, Berlin, Heidelberg 2007; 195–218
   Google Scholar
• Orlic D. Adult BM stem cells regenerate mouse myocardium. Cytotherapy 2002; 4: 521–5
   PubMed Web of Science ®Google Scholar
• Orlic D. Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Ann NY Acad Sci 2003; 996: 152–7
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang P, Guo J, et al. Enhanced cytoprotection and angiogenesis by bone marrow cell transplantation may contribute to improved ischemic myocardial function. Eur J Cardiothorac Surg 2004; 25: 188–95
   PubMed Web of Science ®Google Scholar
• Berry MF, Engler AJ, Woo YJ, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 2006; 290: H2196–203
   PubMed Web of Science ®Google Scholar
• Grinnemo KH, Mansson-Broberg A, Leblanc K, et al. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med 2006; 38: 144–53
   PubMed Web of Science ®Google Scholar
• Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425: 968–73
   PubMed Web of Science ®Google Scholar
• Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10: 494–501
   PubMed Web of Science ®Google Scholar
• Uemura R, Xu M, Ahmad N, et al. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006; 98: 1414–21
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31–47
   PubMed Web of Science ®Google Scholar
• Liao YH, Cheng X. Autoimmunity in myocardial infarction. Int J Cardiol 2006; 112: 21–6
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92: 748–55
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003; 5: 485–9
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 2006; 8: 559–61
   PubMed Web of Science ®Google Scholar
• Ma J, Ge J, Zhang S, et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005; 100: 217–23
   PubMed Web of Science ®Google Scholar
• Varda-Bloom N, Leor J, Ohad DG, et al. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J Mol Cell Cardiol 2000; 32: 2141–9
   PubMed Web of Science ®Google Scholar
• Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res 2006; 312: 2169–79
   PubMed Web of Science ®Google Scholar
• Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol 2007; 28: 219–26
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006; 36: 2566–73
   PubMed Web of Science ®Google Scholar
• Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005; 102: 11474–9
   PubMed Web of Science ®Google Scholar
• Makkar RR, Price MJ, Lill M, et al. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther 2005; 10: 225–33
   PubMed Web of Science ®Google Scholar
• Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389–97
   PubMed Web of Science ®Google Scholar
• Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 2005; 12: 47–57
   PubMed Web of Science ®Google Scholar
• Djouad F, Charbonnier LM, Bouffi C, et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007; 25: 2025–32
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Fazekasova H, Lam EW, et al. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007; 83: 71–6
   PubMed Web of Science ®Google Scholar
• Nian M, Lee P, Khaper N, et al. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004; 94: 1543–53
   PubMed Web of Science ®Google Scholar
• Elahi AW, Vijayakumar AN, Lichstein E, et al. Interplay of antibody and T cell responses in acute myocardial infarction. J Lab Clin Med 2001; 138: 112–8
   PubMed Web of Science ®Google Scholar
• de Scheerder IK, de Buyzere ML, Delanghe JR, et al. Anti-myosin humoral immune response following cardiac injury. Autoimmunity 1989; 4: 51–8
   PubMed Web of Science ®Google Scholar
• Maisel A, Cesario D, Baird S, et al. Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ Res 1998; 82: 458–63
   PubMed Web of Science ®Google Scholar
• Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005; 105: 2214–9
   PubMed Web of Science ®Google Scholar
• Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120–6
   PubMed Web of Science ®Google Scholar
• Sugano M, Tsuchida K, Hata T, et al. In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats. FASEB J 2004; 18: 911–3
   PubMed Web of Science ®Google Scholar
• Capsoni F, Minonzio F, Mariani C, et al. Development of phagocytic function of cultured human monocytes is regulated by cell surface IL-10. Cell Immunol 1998; 189: 51–9
   PubMed Web of Science ®Google Scholar
• Kaur K, Sharma AK, Dhingra S, et al. Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 2006; 41: 1023–30
   PubMed Web of Science ®Google Scholar
• Li B, Liao YH, Cheng X, et al. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int J Cardiol 2006; 111: 247–55
   PubMed Web of Science ®Google Scholar
• Schottelius AJ, Mayo MW, Sartor RB, et al. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 1999; 274: 31868–74
   PubMed Web of Science ®Google Scholar
• Thum T, Bauersachs J, Poole-Wilson PA, et al. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005; 46: 1799–802
   PubMed Web of Science ®Google Scholar